Clot-in-transit: A ticking time bomb in the heart with serious consequences.
Rita IgwiloAlberto PinsinoFeyzullah AksanSumit KapoorPublished in: SAGE open medical case reports (2023)
Clot-in-transit is associated with severe pulmonary embolism and higher mortality than acute pulmonary embolism without clot-in-transit. The optimal treatment of clot-in-transit is not established. Multiple treatment options have been described, including anticoagulation alone, systemic thrombolysis, surgical embolectomy and endovascular catheter-based therapies. Clot-in-transit can embolize to the pulmonary circulation in a matter of seconds and be immediately fatal. We describe two cases of clot-in-transit which embolized quickly upon Intensivist's evaluation and were associated with serious consequences. Management decisions for clot-in-transit should be emergent and based on multidisciplinary discussion of the pulmonary embolism response team.
Keyphrases
- pulmonary embolism
- inferior vena cava
- atrial fibrillation
- heart failure
- palliative care
- pulmonary hypertension
- liver failure
- type diabetes
- drug induced
- venous thromboembolism
- cardiovascular disease
- quality improvement
- cardiovascular events
- early onset
- hepatitis b virus
- intensive care unit
- respiratory failure
- risk factors
- extracorporeal membrane oxygenation
- combination therapy
- aortic dissection
- acute respiratory distress syndrome